Share ownership Bausch Health Companies Inc. Toronto S.E.

BHC

CA0717341071

Pharmaceuticals

Market Closed - Toronto S.E. Other stock markets 16:00:00 2026-06-16 EDT			5-day change	1st Jan Change
6.930 ^CAD	-0.72%		-4.02%	-27.28%

06-12	Alembic Pharma Gets Final NoD From USFDA for Tretinoin Cream	MT
06-01	Bausch + Lomb Launching Triple Care Preservative Free Lubricant Eye Drops in the United States	MT

Share class: Bausch Health Companies Inc.

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	373,812,586	327,582,110 ( 87.63 %)	0	87.63 %

Major shareholders: Bausch Health Companies Inc.

Name	Stocks	%	Valuation
Paulson & Co., Inc. 19.61 %	73,255,869	19.61 %	393 M $
Paulson & Co., Inc. 19.61 %	73,255,869	19.61 %	393 M $
Alex Meruelo 9.843 %	36,761,788	9.843 %	197 M $
GoldenTree Asset Management LP 9.282 %	34,665,731	9.282 %	186 M $
Nomura Securities Co., Ltd. (Private Banking) 4.206 %	15,708,085	4.206 %	84 M $
RBC Dominion Securities, Inc. 3.048 %	11,383,540	3.048 %	61 M $
Nomura Global Financial Products, Inc. 2.406 %	8,986,372	2.406 %	48 M $
Healthcare of Ontario Pension Plan Trust Fund 2.142 %	8,000,000	2.142 %	43 M $
Vanguard Capital Management LLC 1.982 %	7,403,759	1.982 %	40 M $
MFN Partners Management LP 1.607 %	6,000,000	1.607 %	32 M $
░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Breakdown by shareholder type

Institutional	80.35%
Individuals	11.46%
Others	5.51%
ING Groep NV	1.34%
Schweizerische Nationalbank	0.14%
Manulife Financial Corp.	0.06%
Governments	0.05%
Unknown	1.09%

Based on 1000 largest holdings

Geographical origin of shareholders

United States	71.69%
Individuals	11.46%
Canada	6.66%
Japan	4.21%
Netherlands	1.34%
Australia	1%
Norway	0.99%
United Kingdom	0.43%
Germany	0.37%
France	0.31%
Switzerland	0.23%
Ireland	0.1%
Cayman Islands	0.06%
Hong Kong	0.03%
Israel	0.01%
Sweden	0.01%
Luxembourg	0.01%

Based on 1000 largest holdings

Bausch Health Companies Inc. is a global, diversified pharmaceutical company. The Salix segment includes sales in the U.S. of GI products. The International segment includes sales of Bausch + Lomb products and Solta Medical aesthetic medical devices, outside the U.S. and Puerto Rico of branded pharmaceutical products, branded generic pharmaceutical products and OTC products. The Solta Medical segment includes global sales of Solta Medical aesthetic medical devices. The Diversified segment includes sales in the U.S. of pharmaceutical products in the areas of neurology and certain other therapeutic classes, dermatology products, generic pharmaceutical products and dentistry products. The Bausch + Lomb segment includes global sales of Bausch + Lomb Vision Care, Surgical and Pharmaceuticals products. Its drug candidate, Larsucosterol binds to and inhibits the activity of DNA methyltransferases, epigenetic enzymes that are elevated and associated with hypermethylation found in AH patients.

Employees

20,300

Sector

Pharmaceuticals

More about the company